Covered recipient · General Payments record
KATHRYN KARHOFF
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,827.34
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.99 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $211.80 | 15 |
| Abbott Laboratories | $43.96 | 2 |
| Amgen Inc. | $38.58 | 2 |
| Novo Nordisk AS | $35.88 | 2 |
| PFIZER INC. | $27.86 | 2 |
| Lilly USA, LLC | $20.88 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.61 | 1 |
| Janssen Pharmaceuticals, Inc | $17.79 | 1 |
| GlaxoSmithKline, LLC. | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.81 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125366194 | CMS |
| Abbott Laboratories | $21.15 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125366196 | CMS |
| ABBVIE INC. | $7.36 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033059 | CMS |
| ABBVIE INC. | $20.16 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033061 | CMS |
| ABBVIE INC. | $14.26 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033063 | CMS |
| ABBVIE INC. | $19.64 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033065 | CMS |
| ABBVIE INC. | $10.96 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033067 | CMS |
| ABBVIE INC. | $4.50 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033069 | CMS |
| ABBVIE INC. | $14.13 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033071 | CMS |
| ABBVIE INC. | $12.76 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033073 | CMS |
| ABBVIE INC. | $23.68 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033075 | CMS |
| ABBVIE INC. | $9.60 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033077 | CMS |
| ABBVIE INC. | $6.24 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033079 | CMS |
| ABBVIE INC. | $12.00 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033081 | CMS |
| ABBVIE INC. | $10.95 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033083 | CMS |
| ABBVIE INC. | $11.42 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033085 | CMS |
| ABBVIE INC. | $34.14 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104033087 | CMS |
| Amgen Inc. | $21.23 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111614667 | CMS |
| Amgen Inc. | $17.35 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111614669 | CMS |
| GlaxoSmithKline, LLC. | $13.63 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116612514 | CMS |
| Janssen Pharmaceuticals, Inc | $17.79 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078130051 | CMS |
| Lilly USA, LLC | $20.88 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135098882 | CMS |
| Novo Nordisk Inc | $13.37 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097399058 | CMS |
| Novo Nordisk Inc | $22.51 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097153208 | CMS |
| PFIZER INC. | $14.33 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131253896 | CMS |
| PFIZER INC. | $13.53 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131929172 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153706370 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.